Innovation Hub QB3 is a UC system-wide conduit for life science innovation with a track record of launching startups and spinning off venture firms and incubators, indicating a strong network and deal flow potential for collaboration, licensing, and co-development opportunities.

Funding Velocity Companies affiliated with QB3 secured substantial funding, totaling nearly $1B in 2022, suggesting a high-quality portfolio and potential for co-investment, strategic partnerships, and early access to promising technologies.

Industry Partnerships Past and ongoing partnerships with industry leaders and incubators (Sartorius, Gladstone Institutes, MBC Biolabs) indicate openness to collaboration, pilots, and sponsored research programs that can be expanded to new therapeutic modalities or device tech.

Entrepreneurial Ecosystem QB3 operates multiple accelerators and incubators (including Bakar Labs) and supports founders from UC, presenting a ready-made channel for sponsored programs, accelerator collaborations, and distribution of early-stage innovations to market.

Market positioning With a mid-sized talent base and revenue in the low tens of millions, QB3 represents a cost-effective partner for scalable R&D services, technology licensing deals, and joint ventures that leverage university-grade research with industry capital.